Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated whether nefazodone reduces relapse in women with cocaine use disorders; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Serzone (nefazodone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 3 | Status: COMPLETED